Keyphrases
Induced Defects
100%
Lopinavir
100%
Muscle Protein Synthesis
82%
Antiretroviral
80%
Muscle Protein
27%
Skeletal muscle
24%
Synthes
20%
HIV Protease Inhibitors
19%
Protein Balance
14%
Protein Synthesis
14%
Polypeptide Chain
14%
Chain Elongation
14%
Phosphorylation
14%
Protease Inhibitors
12%
Specific Intent
9%
Full Potential
9%
HIV Patients
9%
Long-term Treatment
9%
Per Se
9%
Insulin Resistance
7%
Mammalian Target of Rapamycin (mTOR)
7%
Potentiating Effect
7%
Human Myocytes
7%
Nutritional Signals
7%
Signaling Complex
7%
Zidovudine
7%
In Vitro Model System
7%
EEF2
7%
Leucine
7%
Antiretroviral Agents
7%
Eukaryotic Initiation Factor
7%
Translational Control
7%
Anabolic Stimulus
7%
Initiation Complex
7%
Anabolic Response
7%
Multiple Steps
7%
4E-BP1
7%
Translation Quality
7%
Lamivudine
7%
Carbohydrate Metabolism
7%
Myopathy
7%
Cap-dependent
7%
Cell Growth
7%
Signaling System
7%
Basal Conditions
7%
Metabolic Disturbances
7%
Nutrient Sensing
7%
Lipid Metabolism
7%
Growth Signaling
7%
Drug Class
5%
Interns
5%
Metabolic Phenotype
5%
Muscle Atrophy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Muscle Protein
100%
Lopinavir
100%
Proteinase Inhibitor
22%
HIV
17%
Lamivudine
14%
Zidovudine
14%
Peptide
14%
Human Immunodeficiency Virus Proteinase
9%
Indinavir
9%
Myopathy
9%
Human Immunodeficiency Virus Proteinase Inhibitor
9%
Muscle Atrophy
7%
Insulin Resistance
7%
Viral Protein
7%
Mammalian Target of Rapamycin
7%
Metabolic Disorder
7%
Leucine
7%
Elongation Factor 2
7%
Antiretrovirus Agent
7%
Initiation Factor
7%
Neuroscience
Muscle Protein
80%
Protein Biosynthesis
80%
Skeletal Muscle
21%
Peptide
14%
Lamivudine
14%
Zidovudine
14%
Human Immunodeficiency Virus Proteinase
14%
In Vivo
7%
In Vitro
7%
Metabolic Pathway
7%
Human Immunodeficiency Virus
7%
Mammalian Target of Rapamycin
7%
Amino Acid Activation
7%
Myocyte
7%
Elongation Factor 2
7%
Leucine
7%
Cell Growth
7%
Muscle Disorder
7%
Metabolic Disorder
7%
Indinavir
7%